Clorox (NYSE:CLX) Stock Price Up 4.6% – Here’s Why

Posted by Brenda Bartman on Jun 7th, 2026

The Clorox Company (NYSE:CLX – Get Free Report)’s share price traded up 4.6% during mid-day trading on Friday . The company traded as high as $93.50 and last traded at $93.7570. 1,421,862 shares changed hands during mid-day trading, a decline of 44% from the average session volume of 2,553,910 shares. The stock had previously closed at $89.63.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the stock. Royal Bank Of Canada lowered their target price on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a report on Thursday, April 9th. Jefferies Financial Group lowered their price objective on shares of Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a research note on Monday, May 4th. Weiss Ratings raised shares of Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, April 13th. Zacks Research cut shares of Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, May 12th. Finally, BNP Paribas Exane lowered their price objective on shares of Clorox from $128.00 to $97.00 and set a “neutral” rating for the company in a research note on Tuesday, May 12th. One research analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Reduce” and an average target price of $103.40.

View Our Latest Report on CLX

Clorox Price Performance

The company has a 50-day moving average price of $96.95 and a two-hundred day moving average price of $105.31. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The company has a market cap of $11.37 billion, a PE ratio of 15.27, a P/E/G ratio of 0.49 and a beta of 0.56.

Clorox (NYSE:CLX – Get Free Report) last issued its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, topping the consensus estimate of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter in the prior year, the business earned $1.45 earnings per share. The company’s revenue was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Sell-side analysts expect that The Clorox Company will post 5.61 earnings per share for the current fiscal year.

Insider Buying and Selling at Clorox

In related news, Director Pierre R. Breber bought 5,000 shares of the firm’s stock in a transaction dated Tuesday, May 5th. The stock was bought at an average price of $85.82 per share, with a total value of $429,100.00. Following the completion of the transaction, the director directly owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This represents a 38.46% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.63% of the stock is owned by insiders.

Institutional Trading of Clorox

Several large investors have recently modified their holdings of the business. Wilkins Investment Counsel Inc. lifted its stake in shares of Clorox by 250.6% in the fourth quarter. Wilkins Investment Counsel Inc. now owns 55,064 shares of the company’s stock worth $5,552,000 after acquiring an additional 39,360 shares in the last quarter. ProShare Advisors LLC lifted its stake in shares of Clorox by 11.7% in the third quarter. ProShare Advisors LLC now owns 1,297,016 shares of the company’s stock worth $159,922,000 after acquiring an additional 136,135 shares in the last quarter. JPMorgan Chase & Co. lifted its stake in shares of Clorox by 27.0% in the third quarter. JPMorgan Chase & Co. now owns 928,654 shares of the company’s stock worth $114,506,000 after acquiring an additional 197,330 shares in the last quarter. Morningstar Investment Management LLC lifted its stake in shares of Clorox by 131.8% in the fourth quarter. Morningstar Investment Management LLC now owns 62,454 shares of the company’s stock worth $6,297,000 after acquiring an additional 35,506 shares in the last quarter. Finally, Swiss Life Asset Management Ltd lifted its stake in shares of Clorox by 221.4% in the third quarter. Swiss Life Asset Management Ltd now owns 86,426 shares of the company’s stock worth $10,656,000 after acquiring an additional 59,533 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

About Clorox

(Get Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.